Concepedia

I. B. Esmagambetov

IB

Statistics

Publications

16

Citations

3.3K

H-Index

13

Active since

2014

Affiliations

Ministry of Health of the Russian Federation(Current)

Sechenov University

27th Central Research Institute of the Ministry of Defence of the Russian Federation

Gamalei Institute of Epidemiology and Microbiology

I. B. Esmagambetov is an author at Ministry of Health of the Russian Federation specializing in immunology, medicine, and virology.

ORCID

Top concepts

Publications per year

2014–2023

16

Publications

16

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov et al. · The Lancet · 2021 · 1.8K citations · Full text

, , +10

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Denis Y. Logunov, Inna V. Dolzhikova, Olga V. Zubkova et al. · The Lancet · 2020 · 1.1K citations · Full text

, , +7

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults

Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov et al. · The Lancet Regional Health - Europe · 2021 · 71 citations · Full text

Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin A in Mice

Svetlana A. Godakova, A. N. Noskov, I. D. Vinogradova et al. · Toxins · 2019 · 70 citations · Full text

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern

I. A. FAVORSKAYA, Dmitry V. Shcheblyakov, I. B. Esmagambetov et al. · Frontiers in Immunology · 2022 · 35 citations · Full text

, , +12

1–5 of 16